Skip to content
Pill with imprint LUPIN 40, yellow, round, 8 mm (Lisinopril 40 mg)

“40 mg tablet is a yellow coloured, round, biconvex uncoated tablet with "LUPIN" debossed on one side and "40" on other side”

LUPIN 40 pill

Pill with imprint LUPIN 40 is yellow, round, 8 mm and has been identified as Lisinopril 40 mg. It is used for high blood pressure, heart failure and heart attacks. It is supplied by Blenheim Pharmacal, Inc.

Lisinopril 40 mg

Imprint
LUPIN 40
Strength
40 mg
Used for
High blood pressure, heart failure and heart attacks
Color
Yellow
Shape
Round
Size
8 mm
Score
No score line
Form
Tablet
Manufacturer
Blenheim Pharmacal, Inc
Drug class
ACE inhibitor (blood pressure and heart medicine)
NDC
10544-240, 68180-517, 10544-240-30, 10544-240-60, 33261-109, 33261-109-30, 33261-109-90, 67046-429, 67046-429-30, 63187-237, 63187-237-30, 63187-237-60, 63187-237-90, 54458-872, 54458-872-10, 54458-994, 54458-994-10, 68001-337, 68001-337-00, 68001-337-08, 68001-486, 68001-486-00, 68001-486-08, 71610-624, 68180-979, 71610-624-45, 71610-624-60, 71610-624-80, 68071-3480, 68071-3480-9, 60687-678, 60687-678-11, 60687-678-01, 0615-8405, 0615-8405-05, 0615-8405-39, 67046-2091, 67046-2091-3, 0615-8256, 0615-8256-39

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Lisinopril pills and guides

What is Lisinopril used for?

Lisinopril is used for high blood pressure, heart failure, heart attacks and a weak heart.

Medicine type
ACE inhibitor (blood pressure and heart medicine)
Official uses from the US prescribing label

Hypertension

Lisinopril is indicated for the treatment of hypertension in adult patients and pediatric patients 6 years of age and older to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes.

Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than 1 drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program’s Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC).

Numerous antihypertensive drugs, from a variety of pharmacologic classes and with different mechanisms of action, have been shown in randomized controlled trials to reduce cardiovascular morbidity and mortality, and it can be concluded that it is blood pressure reduction, and not some other pharmacologic property of the drugs, that is largely responsible for those benefits. The largest and most consistent cardiovascular outcome benefit has been a reduction in the risk of stroke, but reductions in myocardial infarction and cardiovascular mortality also have been seen regularly.

Elevated systolic or diastolic pressure causes increased cardiovascular risk, and the absolute risk increase per mmHg is greater at higher blood pressures, so that even modest reductions of severe hypertension can provide substantial benefit. Relative risk reduction from blood pressure reduction is similar across populations with varying absolute risk, so the absolute benefit is greater in patients who are at higher risk independent of their hypertension (for example, patients with diabetes or hyperlipidemia), and such patients would be expected to benefit from more aggressive treatment to a lower blood pressure goal.

Some antihypertensive drugs have smaller blood pressure effects (as monotherapy) in black patients, and many antihypertensive drugs have additional approved indications and effects (e.g., on angina, heart failure, or diabetic kidney disease). These considerations may guide selection of therapy.

Lisinopril may be administered alone or with other antihypertensive agents.

Heart Failure

Lisinopril is indicated to reduce signs and symptoms of systolic heart failure.

Reduction of Mortality in Acute Myocardial Infarction

Lisinopril is indicated for the reduction of mortality in treatment of hemodynamically stable patients within 24 hours of acute myocardial infarction. Patients should receive, as appropriate, the standard recommended treatments such as thrombolytics, aspirin and beta-blockers.

From the FDA-approved label on DailyMed (published Oct 05, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows LUPIN and the other side shows 40.
  • It is yellow, round, 8 mm.
  • The score line, coating and any logo match the photo.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Lisinopril

Inactive: Silicon Dioxide, Anhydrous Dibasic Calcium Phosphate, Magnesium Stearate, Mannitol, Starch, Corn, Ferric Oxide Yellow

Also distributed by

Aidarex Pharmaceuticals LLC, Contract Pharmacy Services-Pa, Proficient Rx LP, International Laboratories, LLC, Bluepoint Laboratories, Aphena Pharma Solutions - Tennessee, LLC, Nucare Pharmaceuticals,inc., American Health Packaging, Ncs Healthcare of Ky, LLC Dba Vangard Labs, Coupler LLC, Lupin Pharmaceuticals, Inc., Major Pharmaceuticals, A-S Medication Solutions, Qpharma, Inc., Northwind Health Company, LLC, Remedyrepack Inc., Quallent Pharmaceuticals Health LLC

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Lisinopril pills